Anorexia nervosa is a serious mental illness characterised by severe restriction of calorie intake and a preoccupation of body weight and shape.
Globally, about 2.2% of women and 0.3% of men suffer from anorexia nervosa at some point in their lives.1
An estimated one in five of people with anorexia nervosa do not recover or improve but go on to develop a long-term or chronic form of the condition.2
Anorexia nervosa also carries the highest mortality rate of all psychiatric disorders3. There is no approved pharmacological treatment option for those living with the illness.
Hear from the trial investigators…
This study uses myPathfinder, Compass’s digital application for supporting patients throughout their COMP360 psilocybin journey. The app is optional for participants in the study, providing engaging education about the therapy model, and with participant consent, collecting real-world data for research on treatment responsiveness.